LSA
CTKB icon

Leonteq Securities AG’s Cytek Biosciences CTKB Stock Holding History

Leonteq Securities AG’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,090
Closed -$7.31K – 1217
2024
Q1 		$7.31K Buy
1,090
+470
+76% +$3.72K ﹤0.01% 1041
2023
Q4 		$5.65K Buy
+620
New +$3.9K ﹤0.01% 1048

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Leonteq Securities AG's CTKB Position: Q2 2024 in Review

Leonteq Securities AG sold out of Cytek Biosciences (CTKB) in Q2 2024, closing a stake of 1,090 shares — an estimated $7.31K sold.

Leonteq Securities AG first reported a position in CTKB in Q4 2023 and held it in 2 quarters. The position peaked at $7.31K in Q1 2024. 128 funds tracked by Wall St. Rank hold CTKB as of Q2 2024.

  • Leonteq Securities AG reported no remaining Cytek Biosciences position as of Q2 2024 after selling out during the quarter.
  • Leonteq Securities AG sold 1,090 Cytek Biosciences shares in Q2 2024, an estimated $7.31K.
  • Leonteq Securities AG first reported a position in Cytek Biosciences in Q4 2023 and held it in 2 quarters.
  • Leonteq Securities AG's Cytek Biosciences position peaked at $7.31K in Q1 2024.
  • 128 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2024.

Based on Leonteq Securities AG's 13F filing for Q2 2024, filed 4 Mar 2026.